Evidence map›Paper›PMID 30192545›Full record

ArticleJournal of proteome research2018

Comparison of an Optimized Ultracentrifugation Method versus Size-Exclusion Chromatography for Isolation of Exosomes from Human Serum.

Mingrui An, Jing Wu, Jianhui Zhu, David M Lubman

Registry-linked trialOpen access · greenAbstract readComparative Study
In one paragraph

Article in Journal of proteome research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04121065 (Interventional Not Pharmacological Study to Investigate the Role of ADA in Multiple Sclerosis PatientsTreated With an Immune-Reconstitution Therapy), which is not on this map. Cited by 122 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed, 2 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04121065 unknown statusnot on this mapstarted 2020, after this paper: background citation

Interventional Not Pharmacological Study to Investigate the Role of ADA in Multiple Sclerosis PatientsTreated With an Immune-Reconstitution Therapy (2-CdA)

TypeobservationalSponsorNeuromed IRCCSRan2020 to 2025Enrolled150ConditionsRelapsing Multiple SclerosisArmsBlood withdrawal
3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 2 syntheses or guidelines pooled it, 208 citations in OpenAlex.

  1. Roles of Exosomes in Chronic Rhinosinusitis: A Systematic Review.International journal of molecular sciences · 2022
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Extracellular Vesicles in Tauopathies: Mechanisms and Applications.International journal of molecular sciences · 2026
    Review
  13. Review
  14. CirculatingFrontiers in cellular and infection microbiology · 2026
    Article
  15. Review
  16. Exosomes in ocular graft-versus-host disease: an overview.International journal of ophthalmology · 2026
    Review
  17. Review
  18. Review
  19. Review
  20. Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mingrui AnDepartment of Surgery , University of Michigan Medical Center , Ann Arbor , Michigan 48109 , United States.
Jing WuDepartment of Surgery , University of Michigan Medical Center , Ann Arbor , Michigan 48109 , United States.
Jianhui ZhuDepartment of Surgery , University of Michigan Medical Center , Ann Arbor , Michigan 48109 , United States.
David M LubmanDepartment of Surgery , University of Michigan Medical Center , Ann Arbor , Michigan 48109 , United States.ORCID 0000-0001-7731-0232
University of Michigan · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI Julie Lynn Boerner · 1985 to 2026
$68.4M
Pilot Project ProgramP30ES020957 · NIEHS · WAYNE STATE UNIVERSITY · PI RUDEN, DOUGLAS M · 2014 to 2021
$10.1M
Microsequencing in an Ion Trap/reTOF DeviceR01GM049500 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUBMAN, DAVID M. · 1994 to 2016
$3.0M
Orbitrap Velos with ETD for Wayne State ProteomicsS10OD010700 · OD · WAYNE STATE UNIVERSITY · PI STEMMER, PAUL M · 2012 to 2012
$575k
Therapeutic Monitoring in Pancreatic Cancer Using an Exosome Based Mass Spec AssayR21CA189775 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUBMAN, DAVID M. · 2015 to 2016
$371k
NCI NIH HHS P30 CA022453NCI NIH HHS R21 CA189775NIEHS NIH HHS P30 ES020957NIGMS NIH HHS R01 GM049500NIH HHS S10 OD010700
6 · The paper itself

Abstract

Exosomes are nanosized vesicles that are abundant in biological fluids. In recent years, exosomes have attracted increasing attention as their cargo may provide promising biomarkers for the early diagnosis of and therapy for many diseases, such as cancer. In addition to ultracentrifugation (UC), many alternative methods including size-exclusion chromatography (SEC) have been developed for isolating exosomes. It has been reported that the SEC method provided improved performance relative to the UC method in isolating exosomes from plasma, where the former contained less residual blood protein contamination. We have compared the SEC method with an optimized UC method in isolating exosomes from human serum. This was based on dilution of the serum to reduce the viscosity and a prolonged cycle of UC, followed by another four cycles. We found that >95% of serum proteins were removed without a significant loss of exosome proteins relative to SEC. We also combined one cycle of UC with SEC and found that this method provided improved results relative to the SEC method, although the serum protein contamination was several times higher than that of our optimized UC method. The TEM showed that the size distribution of exosomes isolated from each of the three methods was similar.

Indexed as

BiomarkersBlood ProteinsChromatography, GelChromatography, LiquidExosomesHumansMicroscopy, Electron, TransmissionParticle SizeReproducibility of ResultsTandem Mass SpectrometryUltracentrifugationBiomarkersBlood ProteinsexosomesSECserumUC

Identifiers

PMID30192545
PMCPMC6292670
OpenAlexW2891272237

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.